Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Universite De Montpellier
Universite De Montpellier 1
Universite De Montpellier I
Universite De Montpellier 2
Universite De Montpellier Ii
Universite De Montpellier 2 Sciences Et Techniques

Universite De Montpellier patents


Recent patent applications related to Universite De Montpellier. Universite De Montpellier is listed as an Agent/Assignee. Note: Universite De Montpellier may have other listings under different names/spellings. We're not affiliated with Universite De Montpellier, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "U" | Universite De Montpellier-related inventors


 new patent  Hydrosilane/lewis acid adduct, particularly aluminum, iron, and zinc, preparing same, and use of said same in reactions for reducing carbonyl derivatives

Disclosed is an adduct between a Lewis acid, preferably aluminum trichloride, iron trichloride, or zinc dichloride, and a hydrosilane;—a method for preparing same; and a method for for reducing, particularly, an aldehyde, a ketone, an α,β-unsaturated ketone, an imine, or an α,β-unsaturated imine.... Universite De Montpellier

Human monoclonal antibodies against orexin receptor type 1

The present disclosure relates to human monoclonal antibodies against orexin receptor type 1 (OX1R, hyprocretin 1) and uses thereof for the treatment of cancer. The antibodies are characterized by their CDRs: NYYMN, YISGSSRNIYYADFVKG, SNYDGMDV (Heavy chain) and AGTSSDVGGSNYVS, PGKAP, SSYTYYSTRV (Light Chain)) or the CDRS having at least 50% or... Universite De Montpellier

Human monoclonal antibodies against axl

The present disclosure provides human monoclonal antibodies and antibody-drug conjugates against AXL and their use for the treatment of cancer.... Universite De Montpellier

Laser device with a beam carrying controlled orbital angular momentum

A laser device is provided for generating a helical-shaped optical wave and includes: (i) a gain region located between one first end defined by a first mirror and a second end defined by an exit region, (ii) a second mirror arranged so as to form with the first mirror an... Universite De Montpellier

Flt3 receptor antagonists for the treatment or the prevention of pain disorders

The present invention relates to FLT3 receptor antagonists or inhibitors of FLT3 receptor gene expression for the treatment or the prevention of pain disorders.... Universite De Montpellier

Novel process for preparing synthesis intermediates using products of natural origin and use of the intermediates obtained

Disclosed is a process for preparing a product of formula I: wherein the reaction is catalyzed both by thiamine or a thiamine salt and by ascorbic acid in a form which is free or salified or an organic acid salt of an alkaline metal, preferably sodium acetate, potassium tartrate, sodium... Universite De Montpellier

Fatty acid polyester derivatives of polyglycosides

Fatty acid polyester derivatives of polyglycosides formed from a polyol having between 2 and 10 hydroxy functions, the 2 hydroxy functions or at least 2 of these hydroxy functions being bound to the anomeric carbon of a reducing carbohydrate that is identical or different for each hydroxy group and selected... Universite De Montpellier

Methods and pharmaceutical compositions for treatment of cystic fibrosis

The present invention relates to a method and compositions for the treatment of cystic fibrosis.... Universite De Montpellier

Method for producing a compound of the sterol biosynthesis pathway in a eukaryotic organism

The invention concerns a method for producing a compound of interest of the sterol biosynthesis pathway in a eukaryotic organism or a derivative of a compound of the sterol biosynthesis pathway in said eukaryotic organism, in particular a sterol. This method comprises a step for the in vitro culturing of... Universite De Montpellier

Dual-frequency vertical-external-cavity surface-emitting laser device for thz generation and generating thz

means for shaping the longitudinal and/or transversal phase profile of the optical wave and arranged for adjusting at least two transverse modes of the optical wave.... Universite De Montpellier

Pyrroloquinoline derivatives as 5-ht6 antagonists, preparation method and use thereof

This invention concerns pyrroloquinoline derivatives as antagonists of 5-HT6 receptors, to methods for the preparation of these compounds and to novel intermediates useful for their synthesis. The invention also relates to the uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic... Universite De Montpellier

Methods for screening a subject for a cancer

The present invention relates to methods for screening a subject for a cancer. In particular, the present invention relates to a method (A) for screening a subject for a cancer comprising the steps of i) extracting the cell free nucleic acids from a sample obtained from the subject, ii) determining... Universite De Montpellier

Flt3 receptor antagonists

The invention pertains to novel FLT3 receptor antagonists of general formula (1). The compounds are useful for the treatment or the prevention of pain disorders, cancer and autoimmune diseases.... Universite De Montpellier

Composition of diblock and triblock copolymers and the use thereof in the prevention of tissue adhesions

Disclosed is a composition based on copolymers including at least one A-B block copolymer, wherein block A is a polyester and block B is a polyoxyethylene (PEG), and wherein the total molecular mass in weight of the PEG is higher than or equal to 50 kDa, and the ethylene oxide... Universite De Montpellier

Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging

R1 and R2 are a hydrogen atom or a (C1-C3) alkyl group.... Universite De Montpellier

Quinoline derivatives for the treatment of inflammatory diseases

The present invention relates to a compound of formula (I) wherein: Formula (II) means an aromatic ring wherein V is C or N and when V is N; Q is N or O, provided that R″ does not exist when Q is O; R′ independently represent a hydrogen atom or... Universite De Montpellier

A quinoline derivative for the treatment of inflammatory diseases and aids

The present invention relates to a compound of formula (1) in the form of a base or addition salt with an acid, particularly a pharmaceutically acceptable acid. It further relates to a pharmaceutical composition including the compound and at least one pharmaceutically acceptable excipient, to a process for preparing said... Universite De Montpellier

Methods and compositions for treating neuropathic pain

The present invention relates to an inhibitor of FXYD2 gene expression for use in a method for treating neuropathic pain in a patient in need thereof. The invention also relates to a pharmaceutical composition comprising an inhibitor of FXYD2 gene expression, wherein said pharmaceutical composition is formulated for a direct... Universite De Montpellier

Methods for predicting the survival time of patients suffering from cancer

The present invention relates to methods for predicting the survival time of patients suffering from cancer. Said methods are based on the quantification and analysis of the cell free nucleic acids that are present in a sample from the patient and typically include the determination of the level of the... Universite De Montpellier

Free nucleic acids and mirna as non-invasive determining embryo quality

The present invention relates generally to the fields of reproductive medicine. More specifically, the present invention relates to in vitro non-invasive methods for determining the quality of an embryo by determining the level of the cell free nucleic acids or miR-29a or let7-b in the nucleic acid extract from a... Universite De Montpellier

Methods employing circulating dna and mirna as biomarkers for female infertility

The present invention relates generally to the fields of reproductive medicine. More specifically, the present invention relates to methods for determining the ovarian reserve and ovarian function by determining the level of cell-free nucleic acids or the level of a miRNA species selected from miR_30_a or miR_140 or let_7_b or... Universite De Montpellier

Early prediction markers of diabetic nephropathy

The present invention concerns a method for the in vitro detection of an increased risk of diabetic nephropathy in a subject suffering from diabetes and being normoalbuminuric. Another aspect of the invention pertains to a method for the in vitro identification of a marker for prediction of diabetic nephropathy. Finally,... Universite De Montpellier

Methods for three dimensional reconstruction and determining the quality of an embryo

The present invention relates generally to the fields of reproductive medicine. More specifically, the present invention relates to methods and devices for determining the quality of an embryo. More specifically, the present invention relates to the use of three dimensional reconstructions for determining the quality of an embryo.... Universite De Montpellier

Vertical external cavity surface emitting laser devices allowing high coherence, high power and large tunability

A laser device is provided for generating an optical wave at a laser frequency, including (i) a semiconductor element having a gain region with quantum wells, the gain region being located between a first mirror and an exit region defining an optical microcavity, (ii) a second mirror distinct from the... Universite De Montpellier

Multiple-junction photovoltaic cell based on antimonide materials

A photovoltaic cell is provided that can be used under high levels of solar concentration (≧1000 suns). The present cell includes at least one junction produced on a substrate based on gallium antimonide, the at least one junction having two alloys based on an antimonide material (Ga1-xAlxAsySb1-y) lattice-matched on the... Universite De Montpellier

Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections

2′ and/or 3′ prodrugs of 1′, 2′, 3′ or 4′-branchednucleosides, and their pharmaceutically acceptable salts and derivatives are described. These prodrugs are useful in the prevention and treatment of Flaviviridae infections, including HCV infection, and other related conditions. Compounds and compositions of the prodrugs of the present invention are described.... Universite De Montpellier

Methods and pharmaceutical compositions for the cardioprotection

The present invention relates to methods and pharmaceutical compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, the present invention relates to a ligand of the sonic hedgehog signaling pathway for use in the cardioprotection of a subject who experienced a myocardial infarction.... Universite De Montpellier

New lipophenol compounds and uses thereof

The present invention relates to a compound of formula (I) wherein: —i is 0 or 1; j is 0 or 1; k is 0 or 1; —R1 and R2 are in particular H, (C1-C12)alkyl, or a group of formula C(O)R; —R is a, linear or branched, alkyl radical, comprising at... Universite De Montpellier

Flavonoid derivative compounds and preparing same by depolymerization of condensed tannins

A compound of general formula (I) in which R1, R2, R3 and R5, identical or different, each represent a hydrogen atom or a hydroxyl group, optionally protected by a protecting group. R4 represents a hydrogen atom or an —OR7 group, in which R7 represents a hydrogen atom, a protecting group... Universite De Montpellier

Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome

The present invention relates to a method for selecting a competent oocyte or a competent embryo by determining the expression level of specific microRNA species in a body fluid or in cumulus cells.... Universite De Montpellier

Novel screening for prostate cancer

The invention relates to a method for the in vitro diagnosis of prostate cancer in a patient, characterised in that it comprises a step of measuring the expression level of the gene of the cation-independent mannose-6-phosphate receptor (CI-M6PR) in a sample of prostate tissue of the patient, the determination of... Universite De Montpellier








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Universite De Montpellier in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Universite De Montpellier with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###